Future Biome develops a prebiótico (a designed carbohydrate) intended to nourish the gut microbiota so it functions properly and helps prevent intestinal inflammation. The company says in vitro trials finished with positive results, outperforming a reference product in 100% of samples. Its first development will enter a clinical trial in Argentina this year, and with positive clinical results the team plans to file a provisional U.S. patent. Go-to-market strategy is B2B via partnerships or licensing with laboratories in Argentina and Europe, with ambitions to reach the U.S., Europe and broader Americas. A second project line is an AI-based bioinformatics platform to enable personalized microbiota products for niches (for example people over 70); the team aims to design and validate it this year and launch in 2024. Financially, the startup raised US$200,000 from Argentine accelerator GridX, which also helped spawn the company. Founders include CEO Martín Larre and scientists Fátima Viceconte and Soledad Gurovic.

Total raised

$0M

Funding rounds

1

Latest round

Equity

Latest activity

Feb 2023